Nanjing Sanhome Pharmaceutical Co., Ltd.
Clinical trials sponsored by Nanjing Sanhome Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New shot SH009 targets tough cancers in early trial Results expected Dec 2026 (estimated)
- New drug SH006 tested in patients with advanced solid tumors Results expected Dec 2026 (estimated)
- New pill combo aims to fight Hard-to-Treat breast cancer Results expected Jun 2027 (estimated)